Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

This study has been completed.
Information provided by (Responsible Party):
Centocor, Inc. Identifier:
First received: December 13, 2005
Last updated: July 1, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2006
  Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)